Liver disease: NAFLD (30.1%); baseline AST/ALT >2x ULN only (12.5%); alcohol (4.2%); viral hepatitis (19.8%); cirrhosis (1.8%); congestive hepatopathy (1.7%); others (29.6%). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.